Jeffrey Shuren, MD, retired as director of the FDA’s medical device division in July. Now, his ties to the industry are being questioned.
Category: Static
The budget area this Louisiana system CEO won't touch
E.J. Kuiper, with two decades of experience in Catholic healthcare leadership, began serving as president and CEO of Baton Rouge, La.-based Franciscan Missionaries of Our Lady Health System in May.
The budget area this Louisiana system CEO won't touch
E.J. Kuiper, with two decades of experience in Catholic healthcare leadership, began serving as president and CEO of Baton Rouge, La.-based Franciscan Missionaries of Our Lady Health System in May.
COO departs 1 HCA hospital for another
Janie Thompson was named COO of Menorah Medical Center in Overland Park, Kan., according to an Aug. 20 release shared with Becker’s.
How an EF5 tornado taught an Oklahoma system CEO authenticity
On Richie Splitt’s second Monday at Norman (Okla.) Regional Health System in 2013, an EF5 tornado swept through Central Oklahoma, killing 24 people and injuring more than 200.
Cleveland Clinic acquires stake in AR company
After a $3 million collaboration, Cleveland Clinic is set to become a shareholder in Strolll, a software that uses augmented reality to help people with Parkinson’s disease.
BayCare creates new virtual care program
Clearwater, Fla.-based BayCare Health System is partnering with Cadence, a chronic disease management company, to launch a remote patient monitoring and responsive virtual care program.
1,100 Providence hospital workers begin strike: 4 things to know
More than 1,100 service and technical workers represented by SEIU Healthcare 1199NW began a seven-day strike Aug. 20 at Kadlec Regional Medical Center in Richland, Wash., and the Kadlec freestanding emergency room in Kennewick, Wash.
FDA approves first-line treatment for lung cancer
Johnson & Johnson’s oncology treatment regimen, Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib), is now approved as a first-line therapy, the drugmaker said Aug. 20.
The specialty where weight loss drug adherence isn't a problem
Many cardiac drugs have notoriously low adherence rates, but GLP-1s may be overcoming that problem, according to Northwell Health cardiologist, Jeffrey Wessler, MD.
